Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004027107 | SCV003653607 | uncertain significance | not specified | 2021-07-06 | criteria provided, single submitter | clinical testing | The c.1019T>A (p.L340Q) alteration is located in exon 2 (coding exon 2) of the PROKR1 gene. This alteration results from a T to A substitution at nucleotide position 1019, causing the leucine (L) at amino acid position 340 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Human Genomics Unit, |
RCV000736048 | SCV000845748 | likely pathogenic | Hirschsprung disease | no assertion criteria provided | research |